Sandro Matosevic

3.2k total citations · 2 hit papers
47 papers, 2.4k citations indexed

About

Sandro Matosevic is a scholar working on Immunology, Oncology and Physiology. According to data from OpenAlex, Sandro Matosevic has authored 47 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 16 papers in Oncology and 10 papers in Physiology. Recurrent topics in Sandro Matosevic's work include Immune Cell Function and Interaction (31 papers), CAR-T cell therapy research (14 papers) and Immune cells in cancer (11 papers). Sandro Matosevic is often cited by papers focused on Immune Cell Function and Interaction (31 papers), CAR-T cell therapy research (14 papers) and Immune cells in cancer (11 papers). Sandro Matosevic collaborates with scholars based in United States, United Kingdom and Denmark. Sandro Matosevic's co-authors include Claudia Zylberberg, Kyle B. Lupo, Andrea M. Chambers, Jiao Wang, Brian M. Paegel, Xue Yao, Frank Baganz, Shadia I. Jalal, Gregory A. Durm and Ahmed Bilal Khalid and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Sandro Matosevic

45 papers receiving 2.3k citations

Hit Papers

Pharmaceutical liposomal drug delivery: a review of new d... 2016 2026 2019 2022 2016 2022 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandro Matosevic United States 24 977 879 833 462 312 47 2.4k
Uma Prabhakar United States 22 806 0.8× 645 0.7× 1.2k 1.4× 810 1.8× 748 2.4× 41 3.1k
Gary L. Griffiths United States 43 524 0.5× 980 1.1× 1.4k 1.6× 475 1.0× 375 1.2× 116 4.6k
Katyayani Tatiparti United States 14 601 0.6× 1.0k 1.1× 871 1.0× 392 0.8× 355 1.1× 19 2.3k
Danilo Marimpietri Italy 30 412 0.4× 578 0.7× 1.5k 1.8× 293 0.6× 396 1.3× 67 2.6k
Tracy R. Daniels‐Wells United States 26 494 0.5× 553 0.6× 1.5k 1.8× 454 1.0× 644 2.1× 51 3.0k
Chensu Wang United States 16 922 0.9× 502 0.6× 947 1.1× 972 2.1× 404 1.3× 26 2.4k
Heather H. Gustafson United States 10 665 0.7× 322 0.4× 896 1.1× 565 1.2× 554 1.8× 14 2.1k
Peixin Liu China 22 352 0.4× 263 0.3× 791 0.9× 541 1.2× 328 1.1× 57 2.1k
Meng Zhou China 20 415 0.4× 261 0.3× 890 1.1× 349 0.8× 450 1.4× 46 1.9k
Mengshi Jiang China 21 802 0.8× 352 0.4× 780 0.9× 1.4k 3.1× 418 1.3× 43 2.3k

Countries citing papers authored by Sandro Matosevic

Since Specialization
Citations

This map shows the geographic impact of Sandro Matosevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandro Matosevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandro Matosevic more than expected).

Fields of papers citing papers by Sandro Matosevic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandro Matosevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandro Matosevic. The network helps show where Sandro Matosevic may publish in the future.

Co-authorship network of co-authors of Sandro Matosevic

This figure shows the co-authorship network connecting the top 25 collaborators of Sandro Matosevic. A scholar is included among the top collaborators of Sandro Matosevic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandro Matosevic. Sandro Matosevic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matosevic, Sandro, et al.. (2025). The diversity of natural killer cell functional and phenotypic states in cancer. Cancer and Metastasis Reviews. 44(1). 26–26. 2 indexed citations
2.
Matosevic, Sandro, et al.. (2025). Pathology, immunosuppression and NK cell immunotherapy of non-small cell lung cancer. Critical Reviews in Oncology/Hematology. 215. 104870–104870. 1 indexed citations
3.
Matosevic, Sandro, et al.. (2025). The differential regulation of the urea cycle in tumors goes awry. Biochemical Pharmacology. 242(Pt 4). 117365–117365.
4.
Lupo, Kyle B., Xue Yao, Jiao Wang, et al.. (2024). synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy. Nature Communications. 15(1). 1909–1909. 25 indexed citations
5.
Matosevic, Sandro, et al.. (2023). Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities. Trends in Pharmacological Sciences. 44(11). 832–848. 15 indexed citations
6.
Lupo, Kyle B., Sandra Torregrosa‐Allen, Bennett D. Elzey, et al.. (2023). TIGIT contributes to the regulation of 4-1BB and does not define NK cell dysfunction in glioblastoma. iScience. 26(12). 108353–108353. 3 indexed citations
7.
Chambers, Andrea M., Kyle B. Lupo, Jiao Wang, et al.. (2022). Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors. eLife. 11. 23 indexed citations
8.
Matosevic, Sandro, et al.. (2022). Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy. Molecular Therapy — Oncolytics. 27. 224–238. 26 indexed citations
9.
Mamdani, Hirva, Sandro Matosevic, Ahmed Bilal Khalid, Gregory A. Durm, & Shadia I. Jalal. (2022). Immunotherapy in Lung Cancer: Current Landscape and Future Directions. Frontiers in Immunology. 13. 823618–823618. 214 indexed citations breakdown →
10.
Yao, Xue & Sandro Matosevic. (2021). Chemokine networks modulating natural killer cell trafficking to solid tumors. Cytokine & Growth Factor Reviews. 59. 36–45. 65 indexed citations
11.
Chambers, Andrea M. & Sandro Matosevic. (2019). Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors. Frontiers in Molecular Biosciences. 6. 60–60. 77 indexed citations
12.
Wang, Yu, Tim Tak Kwok, Fan Xu, et al.. (2019). Axial plane single-molecule super-resolution microscopy of whole cells. Biomedical Optics Express. 11(1). 461–461. 11 indexed citations
13.
Lupo, Kyle B. & Sandro Matosevic. (2019). Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy. Cancers. 11(6). 769–769. 145 indexed citations
14.
Wang, Jiao & Sandro Matosevic. (2018). Adenosinergic signaling as a target for natural killer cell immunotherapy. Journal of Molecular Medicine. 96(9). 903–913. 45 indexed citations
15.
Chambers, Andrea M., Kyle B. Lupo, & Sandro Matosevic. (2018). Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells. Frontiers in Immunology. 9. 2517–2517. 67 indexed citations
16.
Zylberberg, Claudia, et al.. (2017). Engineering liposomal nanoparticles for targeted gene therapy. Gene Therapy. 24(8). 441–452. 164 indexed citations
17.
Matosevic, Sandro & Brian M. Paegel. (2013). Layer-by-layer cell membrane assembly. Nature Chemistry. 5(11). 958–963. 131 indexed citations
18.
Matosevic, Sandro & Brian M. Paegel. (2012). Layer-By-Layer Assembly of Cellular Structures. Biophysical Journal. 102(3). 28a–28a. 1 indexed citations
19.
Matosevic, Sandro, Gary J. Lye, & Frank Baganz. (2011). Immobilised enzyme microreactor for screening of multi-step bioconversions: Characterisation of a de novo transketolase-ω-transaminase pathway to synthesise chiral amino alcohols. Journal of Biotechnology. 155(3). 320–329. 57 indexed citations
20.
Venkiteshwaran, Adith, Patrick L. Heider, Sandro Matosevic, et al.. (2007). Optimized Removal of Soluble Host Cell Proteins for the Recovery of met-Human Growth Hormone Inclusion Bodies from Escherichia coli Cell Lysate Using Crossflow Microfiltration. Biotechnology Progress. 23(3). 667–672. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026